FUNGAL BIOLOGY

Changing things up

Aspergillus fumigatus is a human opportunistic pathogen that can cause life-threatening disease in immunocompromised individuals. Treatment with antifungal drugs is often unsuccessful owing to the emergence of resistance. Cell-to-cell heterogeneity has been linked to drug susceptibility and thus might affect drug treatment. Bleichrodt et al. investigated the composition of cell walls of single fungal conidia cells and how this might affect drug susceptibility. They found that the fungal cell wall is highly heterogeneous and that the level of heterogeneity changed during germination and under different conditions. Investigating whether this heterogeneity has an effect on single cell behaviour, the authors showed that subpopulations of germinating conidia emerged that developed tolerance to a cell wall synthesis-targeting antifungal. Thus, cell wall heterogeneity provides a fitness benefit to A. fumigatus.

References

Original article

  1. Bleichrodt, R.-J. et al. Cell wall composition heterogeneity between single cells in Aspergillus fumigatus leads to heterogeneous behavior during antifungal treatment and phagocytosis. mBio 11, e03015–1919 (2020)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrea Du Toit.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Du Toit, A. Changing things up. Nat Rev Microbiol 18, 362 (2020). https://doi.org/10.1038/s41579-020-0390-3

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing